Audrey Lemacon
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Study of effect modifiers of genetically predicted CETP reduction.
Journal: Genetic epidemiology
Published: July 26, 2022
Pharmacogenomic study of heart failure and candesartan response from the CHARM programme.
Journal: ESC heart failure
Published: September 23, 2021
Genetics of symptom remission in outpatients with COVID-19.
Journal: Scientific reports
Published: March 02, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.
Journal: Circulation. Genomic and precision medicine
Published: February 09, 2021
Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women.
Journal: The pharmacogenomics journal
Published: July 06, 2020
DSNetwork: An Integrative Approach to Visualize Predictions of Variants' Deleteriousness.
Journal: Frontiers in genetics
Published: September 25, 2019
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
Journal: Nature genetics
Published: December 13, 2018
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Journal: Breast cancer research and treatment
Published: October 05, 2016
VEXOR: an integrative environment for prioritization of functional variants in fine-mapping analysis.
Journal: Bioinformatics (Oxford, England)
Published: September 21, 2016
Association analysis identifies 65 new breast cancer risk loci.
Journal: Nature
Published: June 21, 2016
Last Updated: 09/26/2026